secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABVC BIOPHARMA, INC. (ABVC)
CIK:        0001173313
Form:       8-K/A
Filed at:   2025-09-12T23:59:59+00:00
Accession:  0001213900-25-086952
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 4.01
LLM model:  deepseek-v4-flash:cloud@v2

ABVC Biopharma: Former auditor WWC refused to provide letter agreeing with 8-K statements
--------------------------------------------------------------------------------

- WWC, P.C. agreed not to renew engagement on October 10, 2024.
- Company requested WWC provide letter to SEC agreeing with 8-K disclosures.
- As of September 12, 2025 filing, WWC has refused to provide such letter.
- No reason for refusal or any disagreement disclosed in the amendment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1173313/000121390025086952/0001213900-25-086952-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1173313/000121390025086952/ea0256995-8ka1_abvcbio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-086952

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer